For decades, colonoscopies have been marketed as the gold standard for colorectal cancer screening. Millions undergo the procedure each year, convinced it’s the safest and most effective option. But what if the risks are higher than advertised—and what if safer, non-invasive alternatives are being ignored in favor of profit?
